Long noncoding RNAs in cardiovascular disease.

Area of Science:

• Molecular Biology
• Genetics
• Cardiovascular Research

Background:

• Long noncoding RNAs (lncRNAs) are increasingly recognized for their significant roles in cardiovascular disease (CVD).
• Translational evidence from patient studies and animal models highlights specific lncRNAs implicated in CVD pathogenesis.
• Understanding the diverse molecular effector mechanisms of lncRNAs is crucial for advancing CVD research.

Approach:

• Review of recent publications on lncRNA functions in CVD.
• Highlighting novel mechanistic principles revealed by advanced techniques like single-cell profiling and CRISPR/Cas9 screening.
• Focus on how lncRNAs establish RNA-based spatial compartments and how RNA modifications and splicing influence function.

Key Points:

• Cell-type selective modulation of gene expression is a common mechanism for lncRNAs in CVD.
• lncRNAs can form spatial compartments that concentrate effector proteins, influencing cellular processes.
• RNA modifications and splicing features are emerging as critical determinants of lncRNA function in cardiovascular contexts.

Conclusions:

• lncRNA research is moving beyond simple expression analysis to mechanistic understanding.
• Overarching principles of lncRNA function are being uncovered, offering new therapeutic targets for CVD.
• In vivo genetic testing is essential to validate the role of lncRNA loci, motifs, and DNA elements in CVD pathophysiology.